The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


DOCETAXEL MYLAN

20 Mg/Ml Concentrate for Soln for Inf

Mylan S.A.S.EU/1/11/748/001-006

Main Information

Trade NameDOCETAXEL MYLAN
Active SubstancesANHYDROUS DOCETAXEL
Strength20 Mg/Ml
Dosage FormConcentrate for Soln for Inf
Licence HolderMylan S.A.S.
Licence NumberEU/1/11/748/001-006

Group Information

ATC CodeL01CD02 docetaxel

Status

Authorised/WithdrawnAuthorised
Licence Issued31/01/2012
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusNot Marketed

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back